These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32686307)

  • 1. Selective Fragments for the CREBBP Bromodomain Identified from an Encoded Self-assembly Chemical Library.
    Catalano M; Moroglu M; Balbi P; Mazzieri F; Clayton J; Andrews KH; Bigatti M; Scheuermann J; Conway SJ; Neri D
    ChemMedChem; 2020 Sep; 15(18):1752-1756. PubMed ID: 32686307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain.
    Brand M; Clayton J; Moroglu M; Schiedel M; Picaud S; Bluck JP; Skwarska A; Bolland H; Chan AKN; Laurin CMC; Scorah AR; See L; Rooney TPC; Andrews KH; Fedorov O; Perell G; Kalra P; Vinh KB; Cortopassi WA; Heitel P; Christensen KE; Cooper RI; Paton RS; Pomerantz WCK; Biggin PC; Hammond EM; Filippakopoulos P; Conway SJ
    J Med Chem; 2021 Jul; 64(14):10102-10123. PubMed ID: 34255515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of CREBBP Bromodomain Inhibitors by High-Throughput Docking and Hit Optimization Guided by Molecular Dynamics.
    Xu M; Unzue A; Dong J; Spiliotopoulos D; Nevado C; Caflisch A
    J Med Chem; 2016 Feb; 59(4):1340-9. PubMed ID: 26125948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites.
    Olp MD; Sprague DJ; Goetz CJ; Kathman SG; Wynia-Smith SL; Shishodia S; Summers SB; Xu Z; Statsyuk AV; Smith BC
    ACS Chem Biol; 2020 Apr; 15(4):1036-1049. PubMed ID: 32149490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragment-based in silico screening of bromodomain ligands.
    Spiliotopoulos D; Caflisch A
    Drug Discov Today Technol; 2016 Mar; 19():81-90. PubMed ID: 27769362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain.
    Unzue A; Xu M; Dong J; Wiedmer L; Spiliotopoulos D; Caflisch A; Nevado C
    J Med Chem; 2016 Feb; 59(4):1350-6. PubMed ID: 26043365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-encoded chemical libraries: advancing beyond conventional small-molecule libraries.
    Franzini RM; Neri D; Scheuermann J
    Acc Chem Res; 2014 Apr; 47(4):1247-55. PubMed ID: 24673190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.
    Hay DA; Fedorov O; Martin S; Singleton DC; Tallant C; Wells C; Picaud S; Philpott M; Monteiro OP; Rogers CM; Conway SJ; Rooney TP; Tumber A; Yapp C; Filippakopoulos P; Bunnage ME; Müller S; Knapp S; Schofield CJ; Brennan PE
    J Am Chem Soc; 2014 Jul; 136(26):9308-19. PubMed ID: 24946055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-DNA hit validation methodologies for ligands identified from DNA-encoded chemical libraries.
    Prati L; Bigatti M; Donckele EJ; Neri D; Samain F
    Biochem Biophys Res Commun; 2020 Dec; 533(2):235-240. PubMed ID: 32362331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition.
    Ghosh S; Taylor A; Chin M; Huang HR; Conery AR; Mertz JA; Salmeron A; Dakle PJ; Mele D; Cote A; Jayaram H; Setser JW; Poy F; Hatzivassiliou G; DeAlmeida-Nagata D; Sandy P; Hatton C; Romero FA; Chiang E; Reimer T; Crawford T; Pardo E; Watson VG; Tsui V; Cochran AG; Zawadzke L; Harmange JC; Audia JE; Bryant BM; Cummings RT; Magnuson SR; Grogan JL; Bellon SF; Albrecht BK; Sims RJ; Lora JM
    J Biol Chem; 2016 Jun; 291(25):13014-27. PubMed ID: 27056325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.
    Romero FA; Taylor AM; Crawford TD; Tsui V; Côté A; Magnuson S
    J Med Chem; 2016 Feb; 59(4):1271-98. PubMed ID: 26572217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of selective inhibitors for cyclic AMP response element-binding protein: a combined ligand and structure-based resources pipeline.
    Muneer I; Ul Qamar MT; Tusleem K; Abdul Rauf S; Hussain HMJ; Siddiqi AR
    Anticancer Drugs; 2019 Apr; 30(4):363-373. PubMed ID: 30499778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening.
    Zhang FC; Sun ZY; Liao LP; Zuo Y; Zhang D; Wang J; Chen YT; Xiao SH; Jiang H; Lu T; Xu P; Yue LY; Du DH; Zhang H; Liu CP; Luo C
    Acta Pharmacol Sin; 2020 Feb; 41(2):286-292. PubMed ID: 31253937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities.
    Chekler EL; Pellegrino JA; Lanz TA; Denny RA; Flick AC; Coe J; Langille J; Basak A; Liu S; Stock IA; Sahasrabudhe P; Bonin PD; Lee K; Pletcher MT; Jones LH
    Chem Biol; 2015 Dec; 22(12):1588-96. PubMed ID: 26670081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel small molecule induced selective degradation of the bromodomain and extra-terminal (BET) bromodomain protein BRD4 and BRD2 with cellular potencies.
    Jiang F; Wei Q; Li H; Li H; Cui Y; Ma Y; Chen H; Cao P; Lu T; Chen Y
    Bioorg Med Chem; 2020 Jan; 28(1):115181. PubMed ID: 31767403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and Bromodomains.
    Wang J; Erazo T; Ferguson FM; Buckley DL; Gomez N; Muñoz-Guardiola P; Diéguez-Martínez N; Deng X; Hao M; Massefski W; Fedorov O; Offei-Addo NK; Park PM; Dai L; DiBona A; Becht K; Kim ND; McKeown MR; Roberts JM; Zhang J; Sim T; Alessi DR; Bradner JE; Lizcano JM; Blacklow SC; Qi J; Xu X; Gray NS
    ACS Chem Biol; 2018 Sep; 13(9):2438-2448. PubMed ID: 30102854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Based Design of Highly Selective Inhibitors of the CREB Binding Protein Bromodomain.
    Denny RA; Flick AC; Coe J; Langille J; Basak A; Liu S; Stock I; Sahasrabudhe P; Bonin P; Hay DA; Brennan PE; Pletcher M; Jones LH; Chekler ELP
    J Med Chem; 2017 Jul; 60(13):5349-5363. PubMed ID: 28375629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of potent thrombin inhibitors from a protease-focused DNA-encoded chemical library.
    Dawadi S; Simmons N; Miklossy G; Bohren KM; Faver JC; Ucisik MN; Nyshadham P; Yu Z; Matzuk MM
    Proc Natl Acad Sci U S A; 2020 Jul; 117(29):16782-16789. PubMed ID: 32641511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of small-molecule BRD4 degraders based on pyrrolopyridone derivative.
    Zhang J; Chen P; Zhu P; Zheng P; Wang T; Wang L; Xu C; Zhou J; Zhang H
    Bioorg Chem; 2020 Jun; 99():103817. PubMed ID: 32361153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Single-Stranded DNA-Encoded Chemical Library Based on a Stereoisomeric Scaffold Enables Ligand Discovery by Modular Assembly of Building Blocks.
    Bassi G; Favalli N; Vuk M; Catalano M; Martinelli A; Trenner A; Porro A; Yang S; Tham CL; Moroglu M; Yue WW; Conway SJ; Vogt PK; Sartori AA; Scheuermann J; Neri D
    Adv Sci (Weinh); 2020 Nov; 7(22):2001970. PubMed ID: 33240760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.